Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 2, Pages e1046-e1046
Publisher
Springer Nature
Online
2014-02-06
DOI
10.1038/cddis.2014.10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer
- (2013) R. Liu et al. CANCER RESEARCH
- Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer
- (2012) L. Stevenson et al. CLINICAL CANCER RESEARCH
- FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
- (2012) L. E. S. Crose et al. CLINICAL CANCER RESEARCH
- FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior
- (2012) Athina-Myrto Chioni et al. JOURNAL OF CELL BIOLOGY
- Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models
- (2012) Dorothy M. French et al. PLoS One
- The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
- (2011) O Oladipo et al. BRITISH JOURNAL OF CANCER
- Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
- (2011) Vito Guagnano et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer
- (2011) W. L. Allen et al. MOLECULAR CANCER THERAPEUTICS
- The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis
- (2011) Toru Tateno et al. PLoS Genetics
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation
- (2009) A. Roidl et al. CLINICAL CANCER RESEARCH
- FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
- (2009) Xinle Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nuclear EGFR contributes to acquired resistance to cetuximab
- (2009) C Li et al. ONCOGENE
- The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells
- (2009) A Roidl et al. ONCOGENE
- Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice
- (2009) X. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer
- (2008) Weiya Xia et al. MOLECULAR CARCINOGENESIS
- Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells
- (2008) T R Wilson et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now